éå»1ã¶æéã«Vaxcyte Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã11åã«åºã¥ãããŒã¿ã
仿ãPCVXã¯5ä»¶ã®ãè²·ããã1ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããPCVXã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯117.300ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS -1.995ã«ç¶ããPCVXã®FY2026Q4ã®EPSã¯-2.073ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -1.99 ã§ããããVaxcyte IncPCVX ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.97 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -2.07 ãšäºæ³ãããŸãã